Projects funded by the NCN
Addressing the brain glioma temozolomide therapy limitations
2021/41/B/NZ7/03816
Keywords:
temozolomide brain glioma drug carriers multifunctional hydrogel systems biopolymers self-decorated stabilized lipid vesicles
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
dr hab. Joanna Lewandowska-Łańcucka
Number of co-investigators in the project: 10
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 1 524 396 PLN
Project start date (Y-m-d): 2022-02-07
Project end date (Y-m-d): 2025-02-06
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.